Emily Roberts-Thomson

Emily Roberts-Thomson currently serves as the Sr Vice President of Development Operations at Onchilles Pharma, a position held since September 2024. Prior to this, Emily held various important roles at Treadwell Therapeutics, Inc., where responsibilities included Senior Vice President and Vice President of Clinical Operations from April 2020 to September 2024. Emily's experience also spans positions at TIO Bioventures, Acerta Pharma B.V., and Genentech, with roles emphasizing leadership in clinical operations and strategic planning. Notable early career positions included Project Manager at PRA International and Clinical Research Associate at CroMedica Inc. Emily holds a Bachelor of Science degree from the University of Sydney, along with an MMSci in Neuropharmacology and a Graduate Diploma in Medical Sciences from the University of Newcastle.